Kalaris Therapeutics Inc

KLRS · NASDAQ
Analyze with AI
9/30/2025
6/30/2025
3/31/2025
12/31/2024
Assets
Cash & Equivalents$42,387$88,426$100,965$118,289
Short-Term Investments$34,612$0$0$0
Receivables$0$0$0$0
Inventory$0$0$0$0
Other Curr. Assets$1,184$3,225$1,217$257
Total Curr. Assets$78,183$91,651$102,182$118,546
Property Plant & Equip (Net)$1,516$0$0$0
Goodwill$0$0$0$0
Intangibles$0$0$0$0
Long-Term Investments$0$0$0$0
Tax Assets$0$0$0$0
Other NC Assets$1,476$1,191$910$0
Total NC Assets$2,992$1,191$910$0
Other Assets$0$0$0$0
Total Assets$81,175$92,842$103,092$118,546
Liabilities
Payables$494$3,680$2,374$247
Short-Term Debt$376$0$0$0
Tax Payable$0$0$0$0
Deferred Revenue$0$0$0$0
Other Curr. Liab.$5,195$3,971$4,768$4,992
Total Curr. Liab.$6,065$7,651$7,142$5,239
LT Debt$1,169$0$0$0
Deferred Rev, NC$0$0$0$0
Deferred Tax Liab, NC$0$0$0$0
Other NC Liab.$32,076$32,076$32,076$0
Total NC Liab.$33,245$32,076$32,076$0
Other Liabilities$0$0$0$0
Cap. Leases$1,545$0$0$0
Total Liabilities$39,310$39,727$39,218$5,239
Equity
Pref Stock$0$0$0$0
Common Stock$2$2$2$0
Retained Earnings-$150,001-$138,107-$126,757-$714,962
AOCI$6$0$0-$135
Other Equity$191,858$191,220$190,629$828,404
Total Equity$41,865$53,115$63,874$113,307
Supplemental Information
Minority Interest$0$0$0$0
Total Liab. & Tot. Equity$81,175$92,842$103,092$118,546
Net Debt-$40,842-$88,426-$100,965-$118,289
Kalaris Therapeutics Inc (KLRS) Financial Statements & Key Stats | AlphaPilot